Footnotes
ID | footnote |
f1 |
these transactions were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 15, 2021. |
f2 |
represents the weighted average price of the shares sold. the prices actually received ranged from $249.735 to $250.605 per share. the reporting person will provide to the issuer, any security holder of the issuer, or the securities and exchange commission, upon request, information regarding the number of shares sold at each price within the range. |
f3 |
represents the weighted average price of the shares sold. the prices actually received ranged from $255.21 to $255.735 per share. the reporting person will provide to the issuer, any security holder of the issuer, or the securities and exchange commission, upon request, information regarding the number of shares sold at each price within the range. |
f4 |
represents the weighted average price of the shares sold. the prices actually received ranged from $251.21 to $252.195 per share. the reporting person will provide to the issuer, any security holder of the issuer, or the securities and exchange commission, upon request, information regarding the number of shares sold at each price within the range. |
f5 |
represents the weighted average price of the shares sold. the prices actually received ranged from $253.20 to $254.19 per share. the reporting person will provide to the issuer, any security holder of the issuer, or the securities and exchange commission, upon request, information regarding the number of shares sold at each price within the range. |
f6 |
represents the weighted average price of the shares sold. the prices actually received ranged from $252.205 to $253.19 per share. the reporting person will provide to the issuer, any security holder of the issuer, or the securities and exchange commission, upon request, information regarding the number of shares sold at each price within the range. |
f7 |
represents the weighted average price of the shares sold. the prices actually received ranged from $254.215 to $255.205 per share. the reporting person will provide to the issuer, any security holder of the issuer, or the securities and exchange commission, upon request, information regarding the number of shares sold at each price within the range. |
f8 |
represents shares acquired through ongoing participation in cigna's 401(k) plan. |
f9 |
this option was granted on february 26, 2014. the option vested in three equal annual installments on the first, second and third anniversaries of the grant date. |
f10 |
this option was granted on march 5, 2013. the option vested in three equal annual installments on the first, second and third anniversaries of the grant date. |